💨 Abstract

Amphastar Pharmaceuticals reported a second-quarter net income of $31 million, or 64 cents per share. Adjusted earnings were 85 cents per share, beating Wall Street estimates of 71 cents per share. The company's revenue for the period was $174.4 million. However, Amphastar's shares have dropped 42% since the beginning of the year, hitting $21.63

Courtesy: WTOP Staff